Endocrine Society Annual Meeting

A single-injection co-formulation of pramlitide and insulin may be a better alternative to separate administrations of both key treatments in adults with T1D, particularly following meals.

Stimulating steroid receptor co-activators may play a role in repairing heart tissue following severe myocardial infarction.

In ENDO 2021 data, approximately one-third of an observed COVID-19 patient population in Italy was still experiencing signs of thyroid inflammation after 3 months,

Many patients with genetic obesity disorder experience resistance to treatment, including intensive lifestyle therapy.

Evening and late-night preferences of women with GDM is linked to a significantly greater risk of preeclampsia and NICU treatment.

A post-hoc analysis of the AWARD-11 trial indicates that 4.5 mg of dulaglutide was effective in lowering and maintaining A1C levels <7% regardless of baseline levels.

An assessment of the world's largest twin registry found telling patterns of common autoimmune diseases including type 1 diabetes.

No significant differences in cardiovascular outcomes among patients receiving different GLP-1 agonists including exenatide extended-release, exenatide immediate-release, liraglutide, albiglutide, and dulaglutide.

Over the course of 16 weeks, OSA patients receiving CPAP treatment lost 5.7 pounds more on average than patients not receving CPAP therapy.

A year-long outpatient care study showed that patients with type 2 diabetes and comorbid cardiovascular disease are 5 times as likely to visit a cardiologist.

A new Puerto Rico-based trial shows that patients on add-on SGLT-2 inhibitors reported greater HbA1C reductions.

Could insulin could be dosed off of values from a continuous glucose monitor? Anne Peters, MD, and team sought to find out.

Study observed more time in target range, even when adjusted for increased activity.

“Today, hernia is really an endocrine disease,” according to Hong Zhao.

Shanlee Davis, MD, University of Colorado, Children’s Hospital Colorado, and team were interested in the effects of this pre-pubertal androgen treatment on the testicular function, or puberty.

Farid Saad, DVM, PhD, Bayer Pharma AG learned that the men with type 1 diabetes did experience benefits of long-term testosterone therapy – they showed improvements in their underlying diseases.

Researchers are always looking for new ways to use existing medications. That is true for the hormone oxytocin, which a group of researchers recently looked at as a potential weight loss tool for men.

Many male patients with low to moderate levels of testosterone are being diagnosed with depression more often these days. The question then for healthcare professionals becomes how best to treat them.

Childhood can be a stressful enough time without the impact of outside influences and other factors. Healthcare professionals around the country are working to ensure that young gender dysphoria patients get the care and help they need in their process.

Researchers reported no association between endogenous testosterone and incident stroke and ischemic changes in men evaluated via brain MRI imaging.

Due to allergy concerns and changing dietary habits, children (particularly adolescents) are consuming fewer nuts. Some researchers are concerned that the lack of this key food could contribute to other health issues later in life.

Testosterone is not significantly associated with bone mineral density or fracture risk. Estrone, however, may have a role in bone health and fracture prevention in postmenopausal women.

Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

According to a recent retrospective study, orlistat is not associated with hepatotoxic effects after one year of use and it contributes to weight loss in obese patients.

Phase III studies show LDMP to be safe and effective for treatment of vasomotor symptoms in menopausal women.